Abstract
Purpose: In an aspect of qualitative treatment, this research gathered lung cancer patients’ actual experiences to understand deeply, such as their expectation for treatment results, their difficulties during treatment, and their various requests to their family and medical teams. Methods: From May to June 2013, semi-structured interviews were conducted with 9 lung cancer patients. Data were collected through a tape-recorded in-depth interview. The analysis of the data was made through the qualitative method. Results: 124 themes regarding the experience were found. From these 35 concepts, 24 subcategories were emerged. The core category was enduring hardship of the treatment with the hope for full recovery. Six categories included ‘Wishing to be cured but concern about recurrence’, ‘Receiving radiation treatment with pleasure and difficult at the same time’. ‘Being sorry for their family’s full support and trying to stand alone‘, ‘Having confidence in their medical team’, ‘regretting for their old days’, and ‘Wanting to live a long life without illness and pain’. Conclusion: The results of this study would help oncology nurses to understand the lung cancer patients receiving concurrent chemo-radiotherapy (CCRT) and to develop a quality of life improvement program for physical, psychosocial, and spiritual aspects of nursing.
Publisher
Heighten Science Publications Corporation
Reference17 articles.
1. 1. National Cancer Information Center (NCIC). Cancer Incidence Rate. 2021. https://www.cancer.go.kr/lay1/S1T648C650/contents.do
2. 2. National Cancer Information Center (NCIC). Cancer Survival Rate. 2019. https://www.cancer. go.kr/lay1/program/S1T211C215/cancer /view/do?cancer_seg =5237&menu_seg=5253
3. 3. National Comprehensive Cancer Network. NCCN guidelines version 3, 2014. Non-small cell lung cancer. Fort Wahington, PA: National Comprehensive Cancer Networ. 2014. http://www.nccn.org/professionals /physician_gls/pdf/nscl.pdf
4. 4. Kang KM, Jeong BK, Ha IB, Chai GY, Lee GW, et al. Concurrent chemoradiotherapy for elderly patients with stage ΙΙΙ non-small cell lung cancer. Radiat oncol J. 2012; 30: 140-145. PubMed: https://pubmed.ncbi.nlm.nih.gov/23170293/
5. Definitive biomodality concurrent chemoradiotherapy in patients with inoperable N2-positive stage ⅢA non-small cell lung cancer;Noh;Cancer Res Treatment,2015